sábado, 15 de octubre de 2022

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications - eBioMedicine

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications - eBioMedicine

No hay comentarios:

Publicar un comentario